367 related articles for article (PubMed ID: 22927430)
1. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
[TBL] [Abstract][Full Text] [Related]
2. CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells.
Sun RL; Huang CX; Bao JL; Jiang JY; Zhang B; Zhou SX; Cai WB; Wang H; Wang JF; Zhang YL
J Biol Chem; 2016 Sep; 291(37):19532-44. PubMed ID: 27458015
[TBL] [Abstract][Full Text] [Related]
3. Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression.
Fang WB; Sofia Acevedo D; Smart C; Zinda B; Alissa N; Warren K; Fraga G; Huang LC; Shyr Y; Li W; Xie L; Staggs V; Hong Y; Behbod F; Cheng N
Sci Rep; 2021 Apr; 11(1):8708. PubMed ID: 33888841
[TBL] [Abstract][Full Text] [Related]
4. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
[TBL] [Abstract][Full Text] [Related]
5. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
[TBL] [Abstract][Full Text] [Related]
6. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
[TBL] [Abstract][Full Text] [Related]
7. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
[TBL] [Abstract][Full Text] [Related]
8. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
9. Paxillin mediates stretch-induced Rho signaling and endothelial permeability via assembly of paxillin-p42/44MAPK-GEF-H1 complex.
Gawlak G; Tian Y; O'Donnell JJ; Tian X; Birukova AA; Birukov KG
FASEB J; 2014 Jul; 28(7):3249-60. PubMed ID: 24706358
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.
Acevedo DS; Fang WB; Rao V; Penmetcha V; Leyva H; Acosta G; Cote P; Brodine R; Swerdlow R; Tan L; Lorenzi PL; Cheng N
Neoplasia; 2022 Jun; 28():100791. PubMed ID: 35405500
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1-induced activation of p42/44 MAPK and c-Jun in murine peritoneal macrophages: a potential pathway for macrophage activation.
Sodhi A; Biswas SK
J Interferon Cytokine Res; 2002 May; 22(5):517-26. PubMed ID: 12060490
[TBL] [Abstract][Full Text] [Related]
12. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
13. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
[TBL] [Abstract][Full Text] [Related]
14. pp90RSK- and protein kinase C-dependent pathway regulates p42/44MAPK-induced LDL receptor transcription in HepG2 cells.
Kapoor GS; Golden C; Atkins B; Mehta KD
J Lipid Res; 2003 Mar; 44(3):584-93. PubMed ID: 12562867
[TBL] [Abstract][Full Text] [Related]
15. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).
Maffei M; Funicello M; Vottari T; Gamucci O; Costa M; Lisi S; Viegi A; Ciampi O; Bardi G; Vitti P; Pinchera A; Santini F
BMC Biol; 2009 Dec; 7():87. PubMed ID: 20017911
[TBL] [Abstract][Full Text] [Related]
16. The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.
Treviño LS; Bingman WE; Edwards DP; Nl W
Steroids; 2013 Jun; 78(6):542-7. PubMed ID: 23380370
[TBL] [Abstract][Full Text] [Related]
17. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
19. Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
Harrington KM; Clevenger CV
J Biol Chem; 2016 Oct; 291(41):21388-21406. PubMed ID: 27489110
[TBL] [Abstract][Full Text] [Related]
20. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
